297
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Evaluation of Cytotoxicity of the Methanolic Extract of Red Sea Marine Sponge Xestospongia Testudinaria and Its Related Compounds Against MCF-7 Human Breast Cancer Cells

ORCID Icon, , , , ORCID Icon, , ORCID Icon, , , ORCID Icon, & ORCID Icon show all
Pages 879-890 | Received 09 Jul 2023, Accepted 28 Nov 2023, Published online: 07 Dec 2023

References

  • Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3)209–249. doi:10.3322/caac.21660
  • World Health Statistic. Monitoring Health for the SDGs. World Health Statistic; 2019.
  • Almutlaq BA, Almuazzi RF, Almuhayfir AA, et al. Breast cancer in Saudi Arabia and its possible risk factors. J Cancer Policy. 2017;12. doi:10.1016/j.jcpo.2017.03.004
  • Urruticoechea A, Alemany R, Balart J, Villanueva A, Vinals F, Capella G. Recent advances in cancer therapy: an overview. Curr Pharm Des. 2009;16(1):3–10.
  • Baskar R, Lee KA, Yeo R, Yeoh KW. Cancer and radiation therapy: current advances and future directions. Int J Med Sci. 2012;9:193–199. doi:10.7150/ijms.3635
  • Maeda H, Khatami M. Analyses of repeated failures in cancer therapy for solid tumors: poor tumor‐selective drug delivery, low therapeutic efficacy and unsustainable costs. Clin Transl Med. 2018;7(1). doi:10.1186/s40169-018-0185-6
  • Rinehart KL. Secondary metabolites from marine organisms. Ciba Found Symp. 1992;171:236–49; discussion 249–54. doi:10.1002/9780470514344.ch14
  • Zhou X, Xu T, Yang XW, et al. Chemical and biological aspects of marine sponges of the genus Xestospongia. Chem Biodivers. 2010;7:2201–2227. doi:10.1002/cbdv.201000024
  • El-Shitany NA, Shaala LA, Abbas AT, et al. Evaluation of the anti-inflammatory, antioxidant and immunomodulatory effects of the organic extract of the red sea marine sponge xestospongia testudinaria against carrageenan induced rat paw inflammation. PLoS One. 2015;10(9). doi:10.1371/journal.pone.0138917
  • Chaidir LWH, Ebel R, Edrada RA, et al. Rocaglamides, glycosides, and putrescine bisamides from Aglaia dasyclada. J Nat Prod. 2001;64(9):1216–1220. doi:10.1021/np0102354
  • Ying Z, Xu S, Wei C, et al. Epidemiological investigation on a cluster epidemic of COVID-19 in a collective workplace in Tianjin. Chin J Endemiol. 2020;41(5):648–652.
  • Patil AD, Kokke WC, Cochran S, Francis TA, Tomszek T, Westley JW. Brominated polyacetylenic acids from the marine sponge xestospongia muta: inhibitors of HIV protease. J Nat Prod. 1992;55(9):1170–1177. doi:10.1021/np50087a002
  • El-Gamal AA, Al-Massarani SM, Shaala LA, et al. Cytotoxic compounds from the Saudi Red Sea Sponge Xestospongia testudinaria. Mar Drugs. 2016;14:82. doi:10.3390/md14050082
  • Harvey AL, Edrada-Ebel R, Quinn RJ. The re-emergence of natural products for drug discovery in the genomics era. Nat Rev Drug Discov. 2015;14(2):111–129. doi:10.1038/nrd4510
  • Hentschel U, Piel J, Degnan SM, Taylor MW. Genomic insights into the marine sponge microbiome. Nat Rev Microbiol. 2012;10(9):641–654. doi:10.1038/nrmicro2839
  • Aerts LAM. Sponge/coral interactions in Caribbean reefs: analysis of overgrowth patterns in relation to species identity and cover. Mar Ecol Prog Ser. 1998;175. doi:10.3354/meps175241
  • Lee OO, Wang Y, Yang J, Lafi FF, Al-Suwailem A, Qian PY. Pyrosequencing reveals highly diverse and species-specific microbial communities in sponges from the Red Sea. ISME J. 2011;5(4):650–664. doi:10.1038/ismej.2010.165
  • Aslantürk ÖS. In Vitro Cytotoxicity and Cell Viability Assays: principles, Advantages, and Disadvantages. In: Genotoxicity - A Predictable Risk to Our Actual World; 2018. doi10.5772/intechopen.71923
  • Swantara MD, Rita WS, Suartha N, Agustina KK. Anticancer activities of toxic isolate of Xestospongia testudinaria sponge. Vet World. 2019;12(9):1434–1440. doi:10.14202/vetworld.2019.1434-1440
  • Levine AJ. p53, the cellular gatekeeper for growth and division. Cell. 1997;88(3):53. doi:10.1016/S0092-8674(00)81871-1
  • Geurts JMW, Schoenmakers EFPM, Röijer E, Aström AK, Stenman G, van de Ven WJM. Identification of NFIB as recurrent translocation partner gene of HMGIC in pleomorphic adenomas. Oncogene. 1998;16(7):865–872. doi:10.1038/sj.onc.1201609
  • Entschladen F, Palm D, Drell T, Lang K, Zaenker K. Connecting a tumor to the environment. Curr Pharm Des. 2007;13(33):3440–3444. doi:10.2174/138161207782360573
  • Li H, Qiu Z, Li F, Wang C. The relationship between MMP-2 and MMP-9 expression levels with breast cancer incidence and prognosis. Oncol Letters. 2017. doi:10.3892/ol.2017.6924
  • Wagner H, Ulrich-Merzenich G. Synergy research: approaching a new generation of phytopharmaceuticals. Phytomedicine. 2009;16:97–110. doi:10.1016/j.phymed.2008.12.018
  • Williamson EM. Synergy and other interactions in phytomedicines. Phytomedicine. 2001;8(5). doi:10.1078/0944-7113-00060